Альфа-пвп: описание и особенности

Strong compulsive desire for re-dosing is a reported characteristic of Alpha-PVP use. Alpha-PVP crystals often have sharp edges and varying sizes.

It is specifically illegal in New South Wales, Australia, following fatal incidents involving users. Alpha-PVP (alpha-pyrrolidinovalerophenone) is a synthetic cathinone stimulant.

Common street names for Alpha-PVP include 'flakka', 'gravel', and 'niff'. The 'Causeway Cannibal' case was initially linked to bath salts but later forensic evidence did not definitively confirm this link.

Severe adverse effects include paranoia, agitation, hallucinations, delirium, and loss of motor control.

Animal studies show dose-dependent bizarre behavior in rats administered Alpha-PVP. Alpha-PVP is not explicitly scheduled under New Zealand's Misuse of Drugs Act but is controlled via structural similarity provisions.

Psychosis and catatonia have been reported in severe cases of Alpha-PVP use. Alpha-PVP is often sold as a 'designer drug' or disguised as plant fertilizer, bath salts, or research chemicals.

Hypokalemia (low potassium levels) has been observed in cases of Alpha-PVP intoxication. Alpha-PVP is considered a parent compound or closely related to MDPV in structural lineage within the cathinone class.

Routes of administration include smoking, snorting (intranasal), injection, and oral ingestion.

Alpha-PVP and its metabolites can be detected in blood and urine postmortem. Selective blockade of catecholamine transporters may increase addiction risk compared to non-selective substances.

Forensic analysis often uses LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry) to detect Alpha-PVP in biological samples. Structural modifications, such as expanding the pyrrolidine ring to piperidine, significantly reduce potency at dopamine transporters.

Acute effects in humans include euphoria, increased sociability, heightened libido, energy, and time distortion. Alpha-PVP is classified as a synthetic cathinone, part of the 'bath salts' family of designer drugs.

Animal studies indicate that Alpha-PVP induces hyperlocomotion and aberrant or stereotypic behaviors.

The European Union banned Alpha-PVP in 2015. Intranasal administration leads to effects appearing within minutes, lasting approximately 3 hours.

It acts as a psychostimulant with properties similar to cocaine and MDMA. Visual appearance often includes small white or bluish translucent crystals with a shiny surface.

The onset of effects can be subtle or delayed, which may lead to accidental overdosing due to re-dosing. It is a molecular analogue of pyrovalerone and structurally related to MDPV (methylenedioxypyrovalerone).

It was placed under a temporary nationwide ban in the United States effective February 2014.